Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 47)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
20-Nov-09 Zacks Investment Research Inc. N/A 3SBIO INC-ADS (SSRX) Zacks Company Snapshot 1 $10 View Abstract
16-Nov-09 Roth Capital Partners, Inc. James J. Tong PhD 3Q09 Miss, Near Inflection Point, Maintain Buy and $11 PT 7 $25 View Abstract
16-Nov-09 Thomson StreetEvents N/A SSRX - Event Transcript of 3SBIO INC conference call, Nov. 13, 2009 / 9:00pm ET 21 $75 View Abstract
16-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
16-Nov-09 Roth Capital Partners, Inc. Mark Tobin, Sean Jiang ROTH CHINA EDGE: November 6 to 13, 2009 10 $25 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
16-Nov-09 Roth Capital Partners, Inc. James J. Tong PhD 3Q09 Miss, Near Inflection Point, Maintain Buy and $11 PT 7 $25 View Abstract
16-Nov-09 Thomson StreetEvents N/A SSRX - Event Transcript of 3SBIO INC conference call, Nov. 13, 2009 / 9:00pm ET 21 $75 View Abstract
16-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
16-Nov-09 Roth Capital Partners, Inc. Mark Tobin, Sean Jiang ROTH CHINA EDGE: November 6 to 13, 2009 10 $25 View Abstract
13-Nov-09 Roth Capital Partners, Inc. James J. Tong PhD 3Q Results Top Estimates, Again. Raise Estimates, Raise PT to $12.80 6 $25 View Abstract
11-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
10-Nov-09 Roth Capital Partners, Inc. James J. Tong PhD AOB 3Q09 Preview 4 $10 View Abstract
2-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
2-Nov-09 Roth Capital Partners, Inc. Mark Tobin, Sean Jiang ROTH CHINA EDGE: October 23 to 30, 2009 10 $25 View Abstract
30-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 20 $50 View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 25)

Release
Date Contributor Author Title Pages Price More Info
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
20-Nov-09 Zacks Investment Research Inc. N/A 3SBIO INC-ADS (SSRX) Zacks Company Snapshot 1 $10 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
13-Nov-09 Zacks Investment Research Inc. N/A 3SBIO INC-ADS (SSRX) Zacks Company Snapshot 1 $10 View Abstract
13-Nov-09 Validea N/A Validea Guru Analysis Report for SSRX. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
Next 15

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.